Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.61 USD | +2.35% | +6.53% | +53.53% |
04-23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
03-21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.53% | 393M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Heron Therapeutics : Sells $150 Million in Convertible Notes Due 2026 to Fund Launch of Extended-Release Local Anesthetic